5th annual Outsourcing in Clinical Trials West Coast29-30 January 2013, San Francisco
Arena International’s Outsourcing in Clinical Trials, West Coast conference aims to formulate a more proactive approach to perfecting Sponsor-Vendor relationships.
Outsourcing has quickly established itself as an intrinsic accomplice to biopharmaceutical companies and Outsourcing in Clinical Trials West Coast is here to necessitate this demand.
It has been estimated that outsourcing levels will rise to 10-15 per cent of the pharmaceutical industry’s total annual spend of US$490-670 billion. This exemplifies the importance of good CRO governance and fluid trial management and redefines how crucial it is to the trial process.
Outsourcing in Clinical Trials West Coast aims to qualify the skyrocketing importance of strategic vendor selection and management as well as incorporate key changes and advancements within the industry on a national and global scale. The conference will document the level of growth in new markets and show how this approach helps boost productivity and provide our delegates with a unique and comprehensive experience.
The 5th annual Outsourcing in Clinical Trials West Coast conference will explore varied techniques and strategies on how best to maintain consistency and quality and create value for your stock holders.
Trial and Error - Part 3: Indian authorities admit to the failings exposed by The Independent’s investigation into drug tests.
Governments reckon that drug firms’ research efforts need a shot in the arm.
(Reuters) - Big drugmakers, under pressure to streamline operations in the face of rising costs and slowing sales, are looking to the automotive industry for tips ontuning up their profit engines.